EFSCE
TEVA icon

Enterprise Financial Services Corp (EFSC)’s Teva Pharmaceuticals TEVA Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$5K – 1357
2020
Q3 		$5K Sell
500
-346
-41% -$3.66K ﹤0.01% 855
2020
Q2 		$11K Hold
846
– – ﹤0.01% 687
2020
Q1 		$8K Buy
846
+500
+145% +$5.12K ﹤0.01% 700
2019
Q4 		$3K Sell
346
-100
-22% -$893 ﹤0.01% 952
2019
Q3 		$3K Hold
446
– – ﹤0.01% 942
2019
Q2 		$4K Sell
446
-160
-26% -$1.93K ﹤0.01% 940
2019
Q1 		$9K Buy
606
+6
+1% +$106 ﹤0.01% 770
2018
Q4 		$9K Sell
600
-56
-9% -$1.15K 0.01% 552
2018
Q3 		$14K Hold
656
– – 0.01% 514
2018
Q2 		$16K Buy
656
+196
+43% +$4K 0.01% 499
2018
Q1 		$8K Hold
460
– – ﹤0.01% 643
2017
Q4 		$9K Buy
460
+160
+53% +$2.41K ﹤0.01% 602
2017
Q3 		$5K Sell
300
-92
-23% -$2.07K ﹤0.01% 712
2017
Q2 		$13K Sell
392
-89
-19% -$2.75K 0.01% 542
2017
Q1 		$15K Buy
481
+35
+8% +$1.19K 0.01% 533
2016
Q4 		$16K Sell
446
-59
-12% -$2.36K 0.01% 494
2016
Q3 		$23K Sell
505
-3,529
-87% -$184K 0.01% 390
2016
Q2 		$203K Sell
4,034
-123
-3% -$6.55K 0.12% 125
2016
Q1 		$222K Sell
4,157
-6,034
-59% -$354K 0.13% 112
2015
Q4 		$669K Sell
10,191
-3,396
-25% -$210K 0.4% 55
2015
Q3 		$767K Sell
13,587
-107
-0.8% -$6.94K 0.49% 41
2015
Q2 		$809K Buy
13,694
+1,600
+13% +$98.7K 0.48% 43
2015
Q1 		$753K Buy
12,094
+2,810
+30% +$163K 0.44% 43
2014
Q4 		$534K Sell
9,284
-50
-0.5% -$2.79K 0.32% 64
2014
Q3 		$502K Buy
9,334
+2,155
+30% +$114K 0.32% 67
2014
Q2 		$376K Buy
7,179
+5,800
+421% +$296K 0.22% 90
2014
Q1 		$73K Buy
1,379
+30
+2% +$1.39K 0.04% 200
2013
Q4 		$54K Sell
1,349
-59
-4% -$2.32K 0.03% 235
2013
Q3 		$53K Buy
1,408
+63
+5% +$2.46K 0.03% 223
2013
Q2 		$53K Buy
+1,345
New +$52.4K 0.04% 198

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s TEVA Position: Q4 2020 in Review

Enterprise Financial Services Corp (EFSC) sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 500 shares — an estimated $5K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in TEVA in Q2 2013 and held it in 30 quarters. The position peaked at $809K in Q2 2015. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 500 Teva Pharmaceuticals shares in Q4 2020, an estimated $5K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 30 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Teva Pharmaceuticals position peaked at $809K in Q2 2015.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2020, filed 12 Feb 2021.